Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 146 articles:
HTML format
Text format



Single Articles


    November 2017
  1. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Reply to "Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions".
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6173.
    PubMed     Text format    


  2. HARNESS JK, Davies K, Via C, Brooks E, et al
    Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6130.
    PubMed     Text format     Abstract available


  3. COOPEY SB, Specht MC
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-Excision Rates in Breast Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6189.
    PubMed     Text format    


  4. GRANT WB
    Vitamin D Levels Affect Breast Cancer Survival Rates.
    Ann Surg Oncol. 2017 Nov 6. doi: 10.1245/s10434-017-6159.
    PubMed     Text format    


  5. SUGIE T, Toi M
    Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 1. doi: 10.1245/s10434-017-6187.
    PubMed     Text format    


    October 2017
  6. KHOUBNASABJAFARI M, Ansarin K, Jouyban A
    Comments on "An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer".
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6182.
    PubMed     Text format    


  7. BOUGHEY JC, Hoskin TL, Welsh JL, Day CN, et al
    Using Size and Grade to Identify Women Aged >/= 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity : Letter to Editor Reply to "Sized influences nodal status in women aged >/= 70 with endocrine responsive breast can
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6158.
    PubMed     Text format    


  8. KILIC N
    Reply to An Investigation Into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products for Patients with Breast Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6183.
    PubMed     Text format    


  9. PITSINIS V, Wishart GC
    Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6186.
    PubMed     Text format    


  10. CRAGUN D, Vadaparampil S, Scherr C, Pal T, et al
    Comment on "Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey".
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6190.
    PubMed     Text format    


  11. WRAY CJ
    Vitamin D Levels Affect Breast Cancer Survival Rates: A Reply.
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6160.
    PubMed     Text format    


  12. BRICOU A, Sakr R, Barranger E
    Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6188.
    PubMed     Text format    


  13. TOPPS AR, Barr SP, Pikoulas P, Pritchard SA, et al
    Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6090.
    PubMed     Text format     Abstract available


  14. KESKEY RC, LaJoie AS, Sutton BS, Kim IK, et al
    Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6094.
    PubMed     Text format     Abstract available


  15. VIGNES S, Brorson H
    Comment on "Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy".
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6124.
    PubMed     Text format    


    September 2017
  16. GENTILE LF, Plitas G, Zabor EC, Stempel M, et al
    Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2017 Sep 15. doi: 10.1245/s10434-017-6085.
    PubMed     Text format     Abstract available


  17. ZHANG Y, Seely J, Cordeiro E, Hefler J, et al
    Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.
    Ann Surg Oncol. 2017 Sep 14. doi: 10.1245/s10434-017-6084.
    PubMed     Text format     Abstract available


  18. MCLAUGHLIN SA, Cornell LF, Mussallem DM
    Sexual Function and Breast-Specific Sensuality Remain Important After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 Sep 13. doi: 10.1245/s10434-017-6086.
    PubMed     Text format    


  19. DONOVAN CA, Giuliano AE
    Evolution of the Staging System in Breast Cancer.
    Ann Surg Oncol. 2017 Sep 8. doi: 10.1245/s10434-017-6035.
    PubMed     Text format    


  20. ONG CT, Thomas SM, Blitzblau RC, Fayanju OM, et al
    Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
    Ann Surg Oncol. 2017 Sep 6. doi: 10.1245/s10434-017-6075.
    PubMed     Text format     Abstract available


    August 2017
  21. SONG Z, Ye T, Ma L, Xiang J, et al
    Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 28. doi: 10.1245/s10434-017-6067.
    PubMed     Text format     Abstract available


  22. BERGQUIST JR, Murphy BL, Storlie CB, Habermann EB, et al
    Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2017 Aug 21. doi: 10.1245/s10434-017-6010.
    PubMed     Text format     Abstract available


  23. NGUYEN TT, Hieken TJ, Glazebrook KN, Boughey JC, et al
    Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6023.
    PubMed     Text format     Abstract available


  24. MCLAUGHLIN SA, Staley AC, Vicini F, Thiruchelvam P, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5982.
    PubMed     Text format    


  25. KIM SY, Kawaguchi T, Yan L, Young J, et al
    Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5984.
    PubMed     Text format     Abstract available


  26. NGUYEN TT, Hoskin TL, Habermann EB, Cheville AL, et al
    Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5960.
    PubMed     Text format     Abstract available


  27. MENDEZ J, Boughey JC
    Changing Dogma and Decreased Collateral Damage in Breast Cancer Care.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5937.
    PubMed     Text format    


  28. NEWMAN LA
    Breast Cancer Disparities: Socioeconomic Factors versus Biology.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5977.
    PubMed     Text format     Abstract available


  29. ROSSO KJ, Tadros AB, Weiss A, Warneke CL, et al
    Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5952.
    PubMed     Text format     Abstract available


  30. MCLAUGHLIN SA, DeSnyder SM, Klimberg S, Alatriste M, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5964.
    PubMed     Text format    


  31. ELDER EA, Ferlin A, Vallow LA, Li Z, et al
    The Influence of Breast Density on Preoperative MRI Findings and Outcome in Patients with a Known Diagnosis of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5981.
    PubMed     Text format     Abstract available


  32. O'LEARY E, Iacoboni D, Holle J, Michalski ST, et al
    Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5963.
    PubMed     Text format     Abstract available


  33. MUSTAFA RE, DeStefano LM, Bahng J, Yoon-Flannery K, et al
    Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5941.
    PubMed     Text format     Abstract available


  34. SILVERSTEIN MJ, Epstein MS, Lin K, Chen P, et al
    Intraoperative Radiation Using Low-Kilovoltage X-Rays for Early Breast Cancer: A Single Site Trial.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5934.
    PubMed     Text format     Abstract available


  35. HARRIS CK, Tran HT, Lee K, Mylander C, et al
    Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5935.
    PubMed     Text format     Abstract available


  36. SCHUMACHER JR, Taylor LJ, Tucholka JL, Poore S, et al
    Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5933.
    PubMed     Text format     Abstract available


  37. MILLER ME, Muhsen S, Olcese C, Patil S, et al
    Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5931.
    PubMed     Text format     Abstract available


  38. CAUDLE AS, Bedrosian I, Milton DR, DeSnyder SM, et al
    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5958.
    PubMed     Text format     Abstract available


  39. KUERER HM, Vrancken Peeters MTFD, Rea DW, Basik M, et al
    Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5926.
    PubMed     Text format     Abstract available


  40. MURPHY AE, Hussain L, Ho C, Dunki-Jacobs E, et al
    Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5957.
    PubMed     Text format     Abstract available


  41. WENZ F
    Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting : Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5942.
    PubMed     Text format     Abstract available


  42. HESSLER LK, Molitoris JK, Rosenblatt PY, Bellavance EC, et al
    Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5928.
    PubMed     Text format     Abstract available


  43. WELSH JL, Hoskin TL, Day CN, Habermann EB, et al
    Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5932.
    PubMed     Text format     Abstract available


  44. CHAGPAR AB, Hatzis C, Pusztai L, DiGiovanna MP, et al
    Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5936.
    PubMed     Text format     Abstract available


    July 2017
  45. PILEWSKIE M, Zabor EC, Mamtani A, Barrio AV, et al
    The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6016.
    PubMed     Text format     Abstract available


  46. O'NEILL AC, Zhong T, Hofer SOP
    Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6014.
    PubMed     Text format     Abstract available


  47. MCGUIRE A, Lowery AJ, Kell MR, Kerin MJ, et al
    Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
    Ann Surg Oncol. 2017 Jul 28. doi: 10.1245/s10434-017-6021.
    PubMed     Text format     Abstract available


  48. SHUMWAY DA, Griffith KA, Sabel MS, Jones RD, et al
    Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2017 Jul 26. doi: 10.1245/s10434-017-6013.
    PubMed     Text format     Abstract available


  49. CHANG YC, Chen CK, Chen MJ, Lin JC, et al
    Expression of 3beta-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
    Ann Surg Oncol. 2017 Jul 25. doi: 10.1245/s10434-017-6000.
    PubMed     Text format     Abstract available


  50. WAHNER HENDRICKSON AE, Bakkum-Gamez JN, J Couch F, Ghosh K, et al
    Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
    Ann Surg Oncol. 2017 Jul 20. doi: 10.1245/s10434-017-5999.
    PubMed     Text format    


  51. MITTENDORF EA, Chavez-MacGregor M, Vila J, Yi M, et al
    Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
    Ann Surg Oncol. 2017 Jul 19. doi: 10.1245/s10434-017-6009.
    PubMed     Text format     Abstract available


  52. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Jul 17. doi: 10.1245/s10434-017-6004.
    PubMed     Text format    


  53. MCCARTAN DP, Zabor EC, Morrow M, Van Zee KJ, et al
    Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).
    Ann Surg Oncol. 2017 Jul 12. doi: 10.1245/s10434-017-5965.
    PubMed     Text format     Abstract available


  54. AJMANI GS, James TA, Kantor O, Wang CH, et al
    The Impact of Facility Volume on Rates for Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer.
    Ann Surg Oncol. 2017 Jul 6. doi: 10.1245/s10434-017-5969.
    PubMed     Text format     Abstract available


    June 2017
  55. PARK MH, Kwon HJ, Kim JR, Lee B, et al
    Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Jun 20. doi: 10.1245/s10434-017-5907.
    PubMed     Text format     Abstract available


  56. TSANG JYS, Chan KW, Ni YB, Hlaing T, et al
    Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.
    Ann Surg Oncol. 2017 Jun 13. doi: 10.1245/s10434-017-5924.
    PubMed     Text format     Abstract available


    May 2017
  57. NAKHLIS F, Regan MM, Warren LE, Bellon JR, et al
    The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5903.
    PubMed     Text format     Abstract available


  58. CORNELL LF, Mussallem DM, Gibson TC, Diehl NN, et al
    Trends in Sexual Function After Breast Cancer Surgery.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5894.
    PubMed     Text format     Abstract available


  59. MURPHY BL, L Hoskin T, Heins CDN, Habermann EB, et al
    Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
    Ann Surg Oncol. 2017 May 8. doi: 10.1245/s10434-017-5872.
    PubMed     Text format     Abstract available


    April 2017
  60. WONG SM, King T, Boileau JF, Barry WT, et al
    Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2017 Apr 28. doi: 10.1245/s10434-017-5867.
    PubMed     Text format     Abstract available


  61. BEITSCH P, Whitworth P, Baron P, Rotkis MC, et al
    Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
    Ann Surg Oncol. 2017 Apr 26. doi: 10.1245/s10434-017-5863.
    PubMed     Text format     Abstract available


  62. SONG BI, Kim HW, Won KS
    Predictive Value of 18F-FDG PET/CT for Axillary Lymph Node Metastasis in Invasive Ductal Breast Cancer.
    Ann Surg Oncol. 2017 Apr 21. doi: 10.1245/s10434-017-5860.
    PubMed     Text format     Abstract available


  63. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Apr 20. doi: 10.1245/s10434-017-5866.
    PubMed     Text format     Abstract available


  64. DONOVAN CA, Bao J, Gangi A, Amersi F, et al
    Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Apr 17. doi: 10.1245/s10434-017-5856.
    PubMed     Text format     Abstract available


    March 2017
  65. ZHU L, Chen K, Jacobs LK, Aft R, et al
    Axillary Lymphadenectomy in Sentinel Lymph Node-Positive Breast Cancer.
    Ann Surg Oncol. 2017 Mar 31. doi: 10.1245/s10434-017-5849.
    PubMed     Text format    


  66. MORROW M, Hawley ST, McLeod MC, Hamilton AS, et al
    Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2017 Mar 22. doi: 10.1245/s10434-017-5840.
    PubMed     Text format     Abstract available


  67. TRAVIS CLIFTON G, Litton JK, Arrington K, Ponniah S, et al
    Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
    Ann Surg Oncol. 2017 Mar 17. doi: 10.1245/s10434-017-5844.
    PubMed     Text format     Abstract available


    February 2017
  68. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions.
    Ann Surg Oncol. 2017 Feb 22. doi: 10.1245/s10434-017-5807.
    PubMed     Text format     Abstract available


  69. SCHAVERIEN MV, Butler CE
    Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral and Bilateral Reconstructions.
    Ann Surg Oncol. 2017 Feb 13. doi: 10.1245/s10434-017-5809.
    PubMed     Text format    


  70. LIANG Y, Chen X, Zhan W, Garfield DH, et al
    Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease?
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-017-5798.
    PubMed     Text format     Abstract available


  71. TEN WOLDE B, Kuiper M, de Wilt JH, Strobbe LJ, et al
    Postoperative Complications After Breast Cancer Surgery are Not Related to Age.
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-016-5726.
    PubMed     Text format     Abstract available


  72. CHEN HA, Chang YW, Tseng CF, Chiu CF, et al
    Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2017 Feb 3. doi: 10.1245/s10434-017-5769.
    PubMed     Text format    


    January 2017
  73. SCHWARTZ TL, Margenthaler JA
    Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don't Discount the Benefits Yet!
    Ann Surg Oncol. 2017 Jan 17. doi: 10.1245/s10434-017-5766.
    PubMed     Text format    


  74. LANDERCASPER J, Bennie B, Parsons BM, Dietrich LL, et al
    Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.
    Ann Surg Oncol. 2017 Jan 6. doi: 10.1245/s10434-016-5760.
    PubMed     Text format     Abstract available


  75. FELICIANO Y, Mamtani A, Morrow M, Stempel MM, et al
    Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5741.
    PubMed     Text format     Abstract available


  76. BOUGHEY JC, Haffty BG, Habermann EB, Hoskin TL, et al
    Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?
    Ann Surg Oncol. 2017 Jan 4. doi: 10.1245/s10434-016-5740.
    PubMed     Text format    


    December 2016
  77. PUIG CA, Hoskin TL, Day CN, Habermann EB, et al
    National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
    Ann Surg Oncol. 2016 Dec 20. doi: 10.1245/s10434-016-5733.
    PubMed     Text format     Abstract available


    November 2016
  78. BEAR HD, Tang G, Rastogi P, Geyer CE Jr, et al
    The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  79. RAKHRA S, Bethke K, Strauss J, Hayes JP, et al
    Risk Factors Leading to Complications in Early-Stage Breast Cancer Following Breast-Conserving Surgery and Intraoperative Radiotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  80. DE LA CRUZ LM, McDonald ES, Mick R, Datta J, et al
    Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  81. MATEO AM, Pezzi TA, Sundermeyer M, Kelley CA, et al
    Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  82. RADOSA JC, Eaton A, Stempel M, Khander A, et al
    Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  83. WHITWORTH P, Beitsch P, Mislowsky A, Pellicane JV, et al
    Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  84. GRATZON A, Schultz J, Secrest K, Lee K, et al
    Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  85. NEUMAN HB, Schumacher JR, Schneider DF, Winslow ER, et al
    Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  86. FITZSULLIVAN E, Bassett RL, Kuerer HM, Mittendorf EA, et al
    Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  87. CHIBA A, Hoskin TL, Heins CN, Hunt KK, et al
    Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  88. MOGAL HD, Clark C, Dodson R, Fino NF, et al
    Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  89. FLAHERTY DC, Bawa R, Burton C, Goldfarb M, et al
    Breast Cancer in Male Adolescents and Young Adults.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  90. SCHULMAN AM, Mirrielees JA, Leverson G, Landercasper J, et al
    Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO "No Ink on Tumor" Guidelines.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  91. RUIZ A, Wicherts DA, Sebagh M, Giacchetti S, et al
    Predictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  92. SHAH C, Tendulkar R, Smile T, Nanavati A, et al
    Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  93. MCCRAY DK, Simpson AB, Flyckt R, Liu Y, et al
    Erratum to: Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  94. POLVERINI AC, Nelson RA, Marcinkowski E, Jones VC, et al
    Time to Treatment: Measuring Quality Breast Cancer Care.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  95. NEUMAN HB, Schumacher JR, Francescatti AB, Adesoye T, et al
    Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  96. PARIKH RP, Sharma K, Guffey R, Myckatyn TM, et al
    Preoperative Paravertebral Block Improves Postoperative Pain Control and Reduces Hospital Length of Stay in Patients Undergoing Autologous Breast Reconstruction after Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  97. JIAGGE E, Jibril AS, Chitale D, Bensenhaver JM, et al
    Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  98. WARREN LE, Ligibel JA, Chen YH, Truong L, et al
    Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  99. DIXON JM
    Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  100. JAMES TA, Coffman AR, Chagpar AB, Boughey JC, et al
    Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  101. HIEKEN TJ, Mutter RW, Jakub JW, Boughey JC, et al
    Erratum to: A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  102. LAI SF, Chen YH, Kuo WH, Lien HC, et al
    Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  103. GASS J, Dupree B, Pruthi S, Radford D, et al
    Breast Cancer Survivorship: Why, What and When?
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  104. OBENG-GYASI S, Tolnitch L, Greenup RA, Shelley Hwang E, et al
    The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for Treatment.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  105. PLICHTA JK, Rai U, Tang R, Coopey SB, et al
    Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  106. CARTER SA, Lyons GR, Kuerer HM, Bassett RL Jr, et al
    Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  107. BOUGHEY JC, Dietz JR
    Editorial: Management Based on Risk: Individualizing the Care of the Breast Cancer Patient.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  108. ROSENBERGER LH, Mamtani A, Fuzesi S, Stempel M, et al
    Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  109. CLIFFORD E, Hughes KS, Roberts M, Pirzadeh-Miller S, et al
    Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  110. TSAI J, Bertoni D, Hernandez-Boussard T, Telli ML, et al
    Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  111. BEITSCH P, Whitworth P, Baron P, Pellicane J, et al
    Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  112. KWAIT RM, Pesek S, Onstad M, Edmonson D, et al
    Influential Forces in Breast Cancer Surgical Decision Making and the Impact on Body Image and Sexual Function.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  113. MAMTANI A, Gonzalez JJ, Neo D, Slanetz PJ, et al
    Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  114. MURPHY BL, Hoskin TL, Boughey JC, Degnim AC, et al
    Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  115. KUERER HM, van la Parra RF
    Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  116. DE LA CRUZ L, Blankenship SA, Chatterjee A, Geha R, et al
    Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  117. TSAO MW, Cornacchi SD, Hodgson N, Simunovic M, et al
    A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  118. MCCARTAN D, Stempel M, Eaton A, Morrow M, et al
    Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  119. CHIBA A, Hoskin TL, Hallberg EJ, Cogswell JA, et al
    Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  120. MCCRAY DK, Simpson AB, Flykct R, Liu Y, et al
    Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  121. HIEKEN TJ, Mutter RM, Jakub JW, Boughey JC, et al
    A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  122. PAIRAWAN SS, Cora C, Olaya W, Deisch J, et al
    Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  123. EPSTEIN M, Silverstein M, Lin K, Kim B, et al
    Acute and Chronic Complications in Breast Cancer Patients Treated with Intraoperative Radiation Therapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  124. LAI L, Binkley J, Jones V, Kirkpatrick S, et al
    Implementing the Prospective Surveillance Model (PSM) of Rehabilitation for Breast Cancer Patients with 1-Year Postoperative Follow-up, a Prospective, Observational Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  125. ABDELSATTAR JM, Al-Hilli Z, Hoskin TL, Heins CN, et al
    Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  126. MASSIMINO KP, Jochelson MS, Burgan IE, Stempel M, et al
    How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors?
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  127. ATTAI DJ, Hampton R, Staley AC, Borgert A, et al
    What Do Patients Prefer? Understanding Patient Perspectives on Receiving a New Breast Cancer Diagnosis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  128. MAMOUNAS E, Poulos C, Goertz HP, Gonzalez JM, et al
    Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  129. KIM MC, Choi JE, Lee SJ, Bae YK, et al
    Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  130. VILA J, Mittendorf EA, Farante G, Bassett RL, et al
    Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  131. TAN MP
    Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  132. MINAMI CA, Bilimoria KY, Hansen NM, Strauss JB, et al
    National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  133. VALENTE SA, Tendulkar RD, Cherian S, O'Rourke C, et al
    TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  134. BLAIR SL
    A New Technology for Sentinel Node Biopsy: A Logistic Improvement.
    Ann Surg Oncol. 2016;23:1418-9.
    PubMed     Text format    


    March 2016
  135. JOHNSON J, Esserman L, Ewing C, Alvarado M, et al
    Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
    Ann Surg Oncol. 2016;23:715-21.
    PubMed     Text format     Abstract available


  136. MATTOS D, Gfrerer L, Ling IT, Reish RG, et al
    Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
    Ann Surg Oncol. 2016;23:767-75.
    PubMed     Text format     Abstract available


  137. NAKHLIS F, Gilmore L, Gelman R, Bedrosian I, et al
    Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Ann Surg Oncol. 2016;23:722-8.
    PubMed     Text format     Abstract available


  138. JEFFE DB, Perez M, Cole EF, Liu Y, et al
    The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.
    Ann Surg Oncol. 2016;23:735-43.
    PubMed     Text format     Abstract available


  139. SWISHER SK, Vila J, Tucker SL, Bedrosian I, et al
    Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
    Ann Surg Oncol. 2016;23:749-56.
    PubMed     Text format     Abstract available


  140. MA XP, Wang W, Kong Y, Ren Y, et al
    A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy.
    Ann Surg Oncol. 2016;23:796-800.
    PubMed     Text format     Abstract available


  141. NEUMAN HB, Steffens NM, Jacobson N, Tevaarwerk A, et al
    Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.
    Ann Surg Oncol. 2016;23:708-14.
    PubMed     Text format     Abstract available


  142. EDWARDS BL, Guidry CA, Larson KN, Novicoff WM, et al
    Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
    Ann Surg Oncol. 2016;23:782-8.
    PubMed     Text format     Abstract available


  143. MESTAK O, Hromadkova V, Fajfrova M, Molitor M, et al
    Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
    Ann Surg Oncol. 2016;23:776-81.
    PubMed     Text format     Abstract available


  144. MERRILL AL, Coopey SB, Tang R, McEvoy MP, et al
    Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Ann Surg Oncol. 2016;23:729-34.
    PubMed     Text format     Abstract available


  145. SCHAEFGEN B, Mati M, Sinn HP, Golatta M, et al
    Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?
    Ann Surg Oncol. 2016;23:789-95.
    PubMed     Text format     Abstract available


  146. STEFANOVIC S, Diel I, Sinn P, Englert S, et al
    Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.
    Ann Surg Oncol. 2016;23:757-66.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: